The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease

D. L. Price(Vital Therapies (United States)), Douglas W. Bonhaus(Vital Therapies (United States))

Scientific Reports

October 26, 2018

10.1038/s41598-018-34490-9

Cited by 159

Related Papers

No related papers found

Powered by citation graph analysis